A Highly Specific Monoclonal Antibody for Botulinum Neurotoxin Type A-Cleaved SNAP25

Botulinum neurotoxin type-A (BoNT/A), as onabotulinumtoxinA, is approved globally for 11 major therapeutic and cosmetic indications. While the mechanism of action for BoNT/A at the presynaptic nerve terminal has been established, questions remain regarding intracellular trafficking patterns and over...

Descripción completa

Detalles Bibliográficos
Autores principales: Rhéaume, Catherine, Cai, Brian B., Wang, Joanne, Fernández-Salas, Ester, Aoki, K. Roger, Francis, Joseph, Broide, Ron S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516917/
https://www.ncbi.nlm.nih.gov/pubmed/26114335
http://dx.doi.org/10.3390/toxins7072354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516917/
https://www.ncbi.nlm.nih.gov/pubmed/26114335
http://dx.doi.org/10.3390/toxins7072354

Ejemplares similares